Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Surfolase CR vs Capsule in Acute Bronchitis
NCT02792946Phase 3Completed
- Sponsor
- Hyundai Pharmaceutical Co., Ltd.
- Start
- Nov 2015
- Primary completion
- Jan 2016
- Modality
- Small Molecules
01
Overview
Phase 3, randomised trial of acebrophylline in acute bronchitis (2 arms), sponsored by Hyundai Pharmaceutical Co., Ltd. Primary endpoint: Change from Baseline in Bronchitis Severity Score at Day 7. Started Nov 2015; status: completed.
02
Drugs
acebrophylline
03
Conditions
acute bronchitis
Beyond the preview
Go deeper on NCT02792946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02792946.